Citizens Financial Group (CFG) EPS Estimated At $0.59; Argos Therapeutics (ARGS) Shorts Increased By 2.05%

July 3, 2017 - By Vivian Currie

Argos Therapeutics Incorporated (NASDAQ:ARGS) had an increase of 2.05% in short interest. ARGS’s SI was 2.54 million shares in July as released by FINRA. Its up 2.05% from 2.49 million shares previously. With 287,700 avg volume, 9 days are for Argos Therapeutics Incorporated (NASDAQ:ARGS)’s short sellers to cover ARGS’s short positions. The SI to Argos Therapeutics Incorporated’s float is 11.84%. The stock increased 3.48% or $0.012 on June 30, reaching $0.363. About shares traded. Argos Therapeutics Inc (NASDAQ:ARGS) has declined 92.57% since July 3, 2016 and is downtrending. It has underperformed by 109.27% the S&P500.

Analysts expect Citizens Financial Group Inc (NYSE:CFG) to report $0.59 EPS on July, 21 before the open.They anticipate $0.13 EPS change or 28.26% from last quarter’s $0.46 EPS. CFG’s profit would be $299.13 million giving it 15.12 P/E if the $0.59 EPS is correct. After having $0.61 EPS previously, Citizens Financial Group Inc’s analysts see -3.28% EPS growth. The stock increased 0.14% or $0.05 on June 30, reaching $35.68. About shares traded. Citizens Financial Group Inc (NYSE:CFG) has risen 50.96% since July 3, 2016 and is uptrending. It has outperformed by 34.26% the S&P500.

Citizens Financial Group, Inc. is a retail bank holding company. The company has market cap of $18.09 billion. The Firm operates through two divisions: Consumer Banking and Commercial Banking. It has a 16.4 P/E ratio. The Company’s Consumer Banking serves retail clients and small businesses.

Among 22 analysts covering Citizens Financial Group (NYSE:CFG), 8 have Buy rating, 2 Sell and 12 Hold. Therefore 36% are positive. Citizens Financial Group had 45 analyst reports since July 22, 2015 according to SRatingsIntel. The company was upgraded on Wednesday, September 30 by UBS. The firm earned “Buy” rating on Tuesday, January 26 by Compass Point. The firm has “Neutral” rating by Wedbush given on Thursday, November 17. Wells Fargo upgraded Citizens Financial Group Inc (NYSE:CFG) on Friday, May 13 to “Outperform” rating. UBS maintained it with “Buy” rating and $31 target in Monday, October 24 report. On Tuesday, November 8 the stock rating was downgraded by Citigroup to “Neutral”. The rating was upgraded by Ladenburg Thalmann on Monday, October 12 to “Buy”. The rating was maintained by Barclays Capital with “Equal Weight” on Tuesday, January 3. The rating was upgraded by Zacks to “Sell” on Friday, August 21. Wedbush maintained the shares of CFG in report on Wednesday, November 30 with “Neutral” rating.

Investors sentiment increased to 1.12 in 2016 Q4. Its up 0.10, from 1.02 in 2016Q3. It is positive, as 44 investors sold Citizens Financial Group Inc shares while 168 reduced holdings. 95 funds opened positions while 142 raised stakes. 469.78 million shares or 1.33% more from 463.61 million shares in 2016Q3 were reported. The United Kingdom-based Marshall Wace Llp has invested 0.19% in Citizens Financial Group Inc (NYSE:CFG). Gam Holdg Ag, Switzerland-based fund reported 21,065 shares. Ridgeworth Capital Ltd reported 0.45% of its portfolio in Citizens Financial Group Inc (NYSE:CFG). Blackrock Investment Management Lc reported 2.23M shares stake. First Citizens Savings Bank Tru holds 19,020 shares or 0.07% of its portfolio. Rbf Capital Limited Liability stated it has 0.05% of its portfolio in Citizens Financial Group Inc (NYSE:CFG). Frontier Capital Company Limited Liability Corp has invested 0.07% in Citizens Financial Group Inc (NYSE:CFG). Cornerstone Advsrs owns 1,148 shares for 0.03% of their portfolio. Amp Cap Investors Ltd invested in 0.09% or 436,796 shares. Boston Advsrs owns 287,955 shares for 0.25% of their portfolio. Cibc Asset Management Incorporated holds 177,531 shares or 0.05% of its portfolio. D E Shaw Inc invested in 0.12% or 1.96M shares. Piedmont Inv Ltd has 0% invested in Citizens Financial Group Inc (NYSE:CFG) for 772,247 shares. 325 were accumulated by Mufg Americas Hldg. 263,679 are held by Barclays Public Limited Company.

Since February 16, 2017, it had 2 buys, and 0 insider sales for $867 activity. Shares for $523 were bought by HIGDON LEO I JR.

Among 4 analysts covering Argos Therapeutics (NASDAQ:ARGS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Argos Therapeutics had 5 analyst reports since November 16, 2015 according to SRatingsIntel. As per Thursday, August 11, the company rating was maintained by FBR Capital. Needham maintained it with “Buy” rating and $14 target in Tuesday, November 17 report. The stock has “Outperform” rating by FBR Capital on Monday, November 16. JMP Securities maintained the shares of ARGS in report on Wednesday, March 9 with “Market Outperform” rating. The stock of Argos Therapeutics Inc (NASDAQ:ARGS) earned “Buy” rating by Roth Capital on Tuesday, April 19.